中文

First 90 Days

A biopharma bolsters patient centricity and trial diversity goals through newly created role

A biopharma bolsters patient centricity and trial diversity goals through newly created role

Against the backdrop of the industry generally avoiding DEI topics, Ardelyx continues to strengthen its commitment to patient-centricity and clinical trial diversity by creating the new Chief Patient Officer position. New Chief Patient Officer Dr. Laura Williams shared participation data of 45% Black and 28% Hispanic patients in the company's dialysis patient trials, and elaborated on how strategic initiatives embed patient experience into all stages of drug development, approval, and commercialization.

First 90 Days

Our partners

PAI银行新闻网 PAI生物制药新闻网 PAI财务资讯新闻网 PAIIT信息新闻网 PAI银行资讯站 PAI社会新闻网 PAI用户调研新闻网 PAI网络安全新闻网 PAIES综合新闻网 PAI基础设施科技新闻网 PAI食品科技新闻网 PAI生鲜百货新闻网 PAI医疗保健新闻网 PAI高等教育新闻网 PAI酒店新闻网 PAI人力资源新新闻网 PAIK12教育新闻网 PAI制造业新闻网 PAI市场营销新闻网 PAI医疗技术新闻网 PAI住宅新闻网 PAI包装行业新闻网 PAI支付行业新闻网 PAI生物技术新闻网 PAI资本预算新闻网 PAI外卖行业新闻网 PAI智慧零售新闻网 PAI智慧城市新闻网 PAI新媒体营销新闻网 PAI供应链新闻网 PAI运输业新闻网 PAI电力储能新闻网 PAI汽车新闻网